Cargando…
Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are highly prevalent comorbidities in patients with Type 2 diabetes. While many of these patients eventually will need treatment with insulin, little is known about the effects of insulin treatment on hist...
Autores principales: | Jensen, Victoria Svop, Fledelius, Christian, Zachodnik, Christina, Damgaard, Jesper, Nygaard, Helle, Tornqvist, Kristina Steinicke, Kirk, Rikke Kaae, Viuff, Birgitte Martine, Wulff, Erik Max, Lykkesfeldt, Jens, Hvid, Henning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890970/ https://www.ncbi.nlm.nih.gov/pubmed/33596938 http://dx.doi.org/10.1186/s12967-021-02729-1 |
Ejemplares similares
-
Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague–Dawley rats
por: Jensen, Victoria Svop, et al.
Publicado: (2018) -
Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet
por: Svop Jensen, Victoria, et al.
Publicado: (2021) -
Serum lysophospholipid levels are altered in dyslipidemic hamsters
por: Suárez-García, Susana, et al.
Publicado: (2017) -
Anti-hyperglycemic and anti-dyslipidemic activities of methanol ripe fruit extract of Duranta erecta L (Verbenaceae) in normoglycemic and hyperglycemic rats
por: Eke, Ifeanyi Gabriel, et al.
Publicado: (2020) -
Dose-dependent anti-hyperglycemic & anti-dyslipidemic potential of aqueous leaves extract of Typha elephantina in-vivo and in-vitro
por: Ahmad, Bashir, et al.
Publicado: (2023)